Physician profile
Todd A Pepper
NPI 1922192558
$1,496.98
in general payments reported to CMS, 2019-2025
19 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $197 · 2022: $87.72 · 2023: $89.03 · 2024: $262 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $412.85 | 2024-2025 | |
| Lundbeck LLC | $197.97 | 2024-2025 | Vyepti |
| Nevro Corp. | $137.99 | 2019-2023 | Senza |
| Collegium Pharmaceutical, INC. | $115.32 | 2019-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $107.08 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $86.77 | 2020-2024 | |
| Medtronic USA, INC. | $75.98 | 2019-2020 | |
| Fidia Pharma USA INC. | $64.46 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.10 | 2019-2020 | |
| Pfizer INC. | $51.52 | 2019-2025 | |
| Daiichi Sankyo INC. | $48.95 | 2019 | |
| Averitas Pharma INC. | $23.19 | 2025 | Qutenza |
| Abbott Laboratories | $19.16 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.05 | 2023 | Seglentis |
| Ipsen Biopharmaceuticals, INC | $17.00 | 2025 | Dysport |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $16.96 | 2019 | |
| Grt US Holding, INC. | $16.42 | 2022 | |
| Amgen INC. | $16.15 | 2024 | Prolia, Evenity |
| Biodelivery Sciences International, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Pepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.